Pages that link to "Q35597936"

The following pages link to Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside (Q35597936):

Displaying 43 items.

• The legacy of nanotechnology: Revolution and prospects in neurosurgery (Q26866446) (← links)
• Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy (Q28257229) (← links)
• Present and potential future issues in glioblastoma treatment (Q31043603) (← links)
• Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. (Q33828459) (← links)
• Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer (Q33864348) (← links)
• Experimental approaches for the treatment of malignant gliomas (Q34127138) (← links)
• Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer (Q34751465) (← links)
• Clinical development of experimental therapies for malignant glioma. (Q34782295) (← links)
• IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer (Q35064635) (← links)
• Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers (Q35087596) (← links)
• Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells (Q35111932) (← links)
• Targeted therapy for brain tumours (Q35790376) (← links)
• Targeted molecular therapy for malignant gliomas (Q35930279) (← links)
• Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology (Q35939662) (← links)
• Small molecule and monoclonal antibody therapies in neurooncology (Q36108621) (← links)
• Recent advances in the treatment of childhood brain tumors (Q36195156) (← links)
• New delivery approaches for pediatric brain tumors (Q36272990) (← links)
• Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches (Q36273006) (← links)
• Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas (Q36478643) (← links)
• Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy (Q36478656) (← links)
• Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment (Q36499234) (← links)
• Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases (Q36617133) (← links)
• Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications (Q36641509) (← links)
• Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling (Q36686360) (← links)
• Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma (Q36926747) (← links)
• Convection-enhanced delivery for treatment of brain tumors (Q37030814) (← links)
• Targeted therapies for malignant glioma: progress and potential. (Q37159549) (← links)
• Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy (Q37315697) (← links)
• Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme (Q37332250) (← links)
• Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. (Q37444920) (← links)
• Convection-enhanced delivery of therapeutic agents into the brain (Q37974373) (← links)
• IL-13 receptor-directed cancer vaccines and immunotherapy (Q38003478) (← links)
• Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics. (Q38535624) (← links)
• Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells (Q38570271) (← links)
• Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors (Q39462845) (← links)
• Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery (Q39839534) (← links)
• Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model (Q40034753) (← links)
• Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity (Q42133458) (← links)
• Anatomic compression caused by high-volume convection-enhanced delivery to the brain (Q42558659) (← links)
• Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results (Q46842679) (← links)
• Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy (Q47132153) (← links)
• Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue. (Q52715248) (← links)
• Malignant gliomas (Q79969984) (← links)